#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11378	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2131	524.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1384	1384	C	649	C	625	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11378	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2131	524.2	0	HET	.	.	.	C451T	.	451	451	C	651	651	C	590	C,T	323,250	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21182	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3741	559.5	0	.	n	.	0	T695C	SNP	695	695	T	1007	1007	C	617	C	597	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21182	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3741	559.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	1950	1950	G	667	G,A	642,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21182	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3741	559.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2283	2283	C	612	C,T	582,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21182	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3741	559.5	0	.	n	.	0	T2085C	SNP	2085	2085	T	2397	2397	C	575	C,T	288,269	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21182	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3741	559.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2357	2357	A	585	A	569	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21182	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3741	559.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2909	2909	C	679	C	658	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21182	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3741	559.5	0	HET	.	.	.	G256C	.	256	256	G	568	568	G	703	G,C	445,182	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1254	folP	855	855	100.0	folP.l6.c17.ctg.1	1501	82.8	1	SNP	p	R229S	1	.	.	685	687	AGC	997	999	AGC	115;115;117	A;G;C	111;109;113	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4066	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3584	112.2	1	SNP	p	S91F	1	.	.	271	273	TTC	704	706	TTC	129;129;131	T;T;C	127;126;130	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4066	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3584	112.2	1	SNP	p	D95G	1	.	.	283	285	GGC	716	718	GGC	125;123;123	G;G;C	120;115;119	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4066	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3584	112.2	1	SNP	p	G95N	0	.	.	283	285	GGC	716	718	GGC	125;123;123	G;G;C	120;115;119	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1232	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1406	86.4	1	SNP	p	G45D	0	.	.	133	135	GGC	491	493	GGC	139;138;136	G;G;C	137;136;134	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	664	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1032	63.6	0	.	n	.	0	A197.	DEL	197	197	A	606	606	A	133	A	129	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4016	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2939	134.7	1	SNP	p	D86N	0	.	.	256	258	GAC	574	576	GAC	156;153;155	G;A;C	150;140;150	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4016	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2939	134.7	1	SNP	p	S87R	1	.	.	259	261	CGT	577	579	CGT	156;159;158	C;G;T	151;153;145	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4016	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2939	134.7	1	SNP	p	R87W	0	.	.	259	261	CGT	577	579	CGT	156;159;158	C;G;T	151;153;145	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4016	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2939	134.7	1	SNP	p	R87I	0	.	.	259	261	CGT	577	579	CGT	156;159;158	C;G;T	151;153;145	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4016	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2939	134.7	1	SNP	p	S88P	0	.	.	262	264	TCC	580	582	TCC	159;159;161	T,A;C;C	151,1;153;155	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2860	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2649	106.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1501	1503	GGC	114;113;111	G;G;C	109;108;106	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1216	1218	GCC	176;180;180	G;C;C	170;175;175	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1219	1221	ATG	178;179;177	A;T;G	174;174;169	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1231	1233	ACC	181;181;181	A;C;C	173;175;179	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1231	1233	ACC	181;181;181	A;C;C	173;175;179	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1732	1734	ACC	133;137;140	A;C;C	121;128;132	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1786	1788	GCG	127;128;132	G;C;G	126;126;130	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1786	1788	GCG	127;128;132	G;C;G	126;126;130	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1909	1911	GGT	125;126;126	G;G;T	120;121;117	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1918	1920	AGC	122;121;121	A;G;C,T	117;118;116,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3020	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2330	127.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1936	1938	CCG	96;100;98	C,G;C;G	85,2;89;86	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4646	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3136	146.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1649	1651	CCG	147;147;148	C;C;G,C	137;140;137,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1754	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1697	101.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	506	506	C	140	C	129	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	188	90.1	porB1a.l15.c30.ctg.2	255	17.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	86	88	AAT	10;10;10	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	188	90.1	porB1a.l15.c30.ctg.2	255	17.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	89	91	AAT	10;10;10	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	188	90.1	porB1a.l15.c30.ctg.2	255	17.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	113	115	GCA	9;9;9	G;C;A	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	188	90.1	porB1a.l15.c30.ctg.2	255	17.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	136	138	GTA	9;10;10	G;T;A	9;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	188	90.1	porB1a.l15.c30.ctg.2	255	17.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	145	145	A	8	A	8	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2302	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1644	138.2	0	.	p	.	0	G48E	NONSYN	142	144	GGA	432	434	GAA	191;191;194	G;A;A	182;180;185	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2302	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1644	138.2	0	.	p	.	0	Q143K	NONSYN	427	429	CAA	717	719	AAA	201;196;200	A;A,C;A	194;187,1;194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2302	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1644	138.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	918	920	AGA	197;197;196	A;G;A,G	192;188;190,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2302	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1644	138.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	939	941	GGT	187;191;188	G;G;T	178;184;175	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2302	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1644	138.2	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	174;178;177	A;A;G	165;172;165	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2302	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1644	138.2	1	SNP	p	A121N	1	.	.	361	363	AAC	651	653	AAC	176;176;175	A,G;A;C	168,1;171;169	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2302	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1644	138.2	1	SNP	p	N121D	0	.	.	361	363	AAC	651	653	AAC	176;176;175	A,G;A;C	168,1;171;169	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7894	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4875	160.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	858	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1049	81.0	1	SNP	p	V57M	1	.	.	169	171	ATG	511	513	ATG	181;187;188	A;T;G	178;182;185	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
